Israeli Company Creates Successful Blood Test for Lung Cancer

Israeli Company Creates Successful Blood Test for Lung Cancer

Credit:(Photo: flickr/pulmonary_pathology)

A new Israeli test for lung cancer allows doctors to catch the disease while patients still have a good chance of recovery.

The Israeli company Savicell has developed a successful blood test for lung cancer, allowing the disease to be detected and treated in its earliest stages, thus boosting the chances of recovery.

Dr. Shafrira Shai — the development and production manager of Savicell — was quoted by the Hebrew news outlet Mako as saying, “This process in fact identifies the energetic profile of the cells created as a result of their specific reactions. This gives us exact information on the condition of the person, if he’s in pre-cancerous condition, the beginning stages of cancer, or other possibilities.”

Eyal Davidovitch — the company’s vice president of operations — emphasized the importance of the new test.

“Statistics indicate that if you discover lung cancer in an early stage, the chances of recovery wander on average between 50-80 percent,” he said. “If you identify it at a late stage, we’re talking about four percent — it’s unbelievable. Lung cancer is the number one killer.”

Tags: Israeli Innovation

More From Fellowship Blog

Fellowship Blog

Creating Israel’s National Diet

Sarah Bavly was a chemist and nutritionist whose decades of work helped better the health of the people of Israel.

Fellowship Blog

6 Reasons for Aliyah

Here are six major reasons why The Fellowship and our faithful friends continue to bring Jewish people home to Israel.

Fellowship Blog

A Real Life Wonder Woman

A Christian nurse who saved more than 2,500 Jewish children from the Nazis during WWII, Irena Sendler will be played on the big screen by Israeli actress Gal Gadot.

Subscribe to our Newsletter

Stay informed about issues affecting Israel, the Jewish people, Jewish-Christian relations, receive daily devotionals, and more.